Eng

Update: Apple to expand applied research lab in China

XINHUA
發布於 03月12日06:35 • Cheng Lu,Wang Chenyang,Chang Yuanyidu
People try new Apple products after their launch in Cupertino, California, the United States, Sept. 12, 2023. (Xinhua/Wu Xiaoling)

SHANGHAI, March 12 (Xinhua) -- U.S. tech giant Apple announced on Tuesday that it will expand its applied research lab in Shanghai and establish a new lab in Shenzhen later this year.

The labs in Shanghai and Shenzhen will support intelligent manufacturing, along with the reliability, quality, and material analysis of products, providing resources for the global engineering and design team, according to Isabel Ge Mahe, Apple's vice president and managing director of Greater China.

廣告(請繼續閱讀本文)

Apple said it has cumulatively invested 1 billion yuan (about 140 million U.S. dollars) in building applied research labs in China.

Apple has been working on development in China for over 30 years. Data shows that 151 out of the company's 200 major suppliers have production activities in China.

Currently, it has research and development centers in Beijing, Shanghai, Suzhou and Shenzhen. Over the past five years, its research and development team in China has doubled in size. ■

廣告(請繼續閱讀本文)

更多 Eng 相關文章

China's "new third board" companies report revenue growth for 3 straight years
XINHUA
Update: Chinese premier chairs State Council executive meeting
XINHUA
Style news: Hailey Bieber announces pregnancy, K-pop band Riiize wears Louis Vuitton and more
Tatler Hong Kong
Glasses in Moon's soil preserve water from multiple sources: study
XINHUA
Huawei Launching the All-Scenario Smart Telecom Power Solutions
PR Newswire (美通社)
China's consumer prices show mild upticks amid continued demand recovery
XINHUA
Fun88 India Launches 'Fun88 X Evolution' for Guaranteed Wins
PR Newswire (美通社)
Beijing bourse facilitates treasury bond issuance of 1.46 trln yuan in Jan-April
XINHUA
China Brand Day 2024 events underway in Shanghai
XINHUA
MiaoVlogs | What's the right path for China-Europe ties?
XINHUA
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology
PR Newswire (美通社)
China Sports Weekly (5.5-5.11)
XINHUA
Distinctive industries help SW China's township escape poverty
XINHUA
Voting ends in 2nd round of Iran's parliamentary election
XINHUA
Xinhua News | Xi stresses breaking new ground in ideological, political education
XINHUA
GLOBALink | Foreign tea traders upbeat about business prospect of China's tea market
XINHUA
Xinhua News | China has 5.63 mln registered nurses
XINHUA
Xinhua News | Direct flight links China's Shenzhen with Mexico City
XINHUA
Xinhua News | World Brand Moganshan Conference opens in China's Zhejiang
XINHUA
GLOBALink | Hungarian officials voice confidence in the future of China-Hungary relations
XINHUA
Interview: To invest in China is to invest in the future, says L'Oreal executive
XINHUA
InPics | Ethiopia, Djibouti embark on management, operation of Chinese-built railway
XINHUA